NCT02897154View on ClinicalTrials.gov

Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

May 10, 2016

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Analytical Performance of Sodium, Glucose and Hematocrit Assays by the i-STAT 500 (Alinity) Analyzer
Interventions
DIAGNOSTIC_TEST

In-vitro

Trial Locations (3)

40202

Kentucky Clinical Trials Laboratory, Louisville

44195

Cleveland Clinic, Cleveland

94598

Diablo Clinical Research, Walnut Creek

All Listed Sponsors
lead

Abbott Point of Care

INDUSTRY

NCT02897154 - Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples | Biotech Hunter | Biotech Hunter